ARTICLE | Clinical News
Epogin epoetin beta regulatory update
June 20, 2011 7:00 AM UTC
A committee within Japan's Ministry of Health, Labor, and Welfare (MHLW) recommended against expanding the indication for Epogin epoetin beta from Chugai Pharmaceutical Co. Ltd. (Tokyo:4519; Tokyo, Japan) to include chemotherapy-induced anemia. The erythropoiesis-stimulating agent (ESA) is already approved to treat anemia associated with chronic kidney disease (CKD) and for use in autologous blood transfusions. ...